REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/12/2026
Back to search
Official data from USPTO
DAVA PHARMACEUTICALS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
DAVA PHARMACEUTICALS, INC.
ST13
US500000078778968Class
5
Filing
78778968
Registration
3250845
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/13/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
12/22/2005
Registration date
06/12/2007
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/03/2016
Last transaction
06/13/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/18/2004
First use in commerce
02/18/2004
Drawing code
4
Owner type
99
Owner location
BALLSBRIDGE, DUBLIN 4, IE
Examiner
STEPHENS, SONYA B
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PH HEALTH LIMITED
ENDO OPERATIONS LIMITED
DAVA Pharmaceuticals, Inc.
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Housemark for a full line of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
35 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/26/2026
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/02/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/14/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/28/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/01/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/22/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/03/2017
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/03/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/03/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/03/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/03/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
06/13/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/12/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/01/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/01/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/12/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/11/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/11/2013
E815
TEAS SECTION 8 & 15 RECEIVED
05/24/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2007
PUBO
PUBLISHED FOR OPPOSITION
03/27/2007
NPUB
NOTICE OF PUBLICATION
03/07/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/12/2007
ALIE
ASSIGNED TO LIE
02/12/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/09/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/23/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2006
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/18/2006
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/18/2006
GNRT
NON-FINAL ACTION E-MAILED
06/27/2006
CNRT
NON-FINAL ACTION WRITTEN
06/27/2006
DOCK
ASSIGNED TO EXAMINER
06/20/2006
NWAP
NEW APPLICATION ENTERED
12/30/2005
Continuous trademark protection
Get notified about every new filing that threatens DAVA PHARMACEUTICALS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.